Q4 Earnings for J&J, Procter, GE & More
https://www.zacks.com/stock/news/2214313/q4-earnings-for-j-j-procter-ge-more?cid=CS-ZC-FT-ahead_of_wall_street-2214313
Jan 23, 2024 - Pre-market trading fortunes are mixed for this morning's reportees, including JNJ, PG, GE, MMM and DHI.
0
Johnson & Johnson (JNJ) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2214282/johnson-johnson-jnj-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2214282
Jan 23, 2024 - The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
JNJ looking to move talc powder unit to Texas ahead of bankruptcy filing: report
https://seekingalpha.com/news/4056938-jnj-looking-to-move-talc-powder-unit-to-texas-ahead-of-bankruptcy-filing-report?source=feed_sector_healthcare
Jan 22, 2024 - Johnson & Johnson (JNJ) is reportedly looking to relocate its LTL talc powder unit to Texas ahead of an expected third bankruptcy filing for the subsidiary. Read more here.
0
Alvotech (ALVO) Up on BLA Update for Two Biosimilar Candidates
https://www.zacks.com/stock/news/2213525/alvotech-alvo-up-on-bla-update-for-two-biosimilar-candidates?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2213525
Jan 22, 2024 - The FDA concludes the reinspection of Alvotech's (ALVO) facility in Iceland. The company believes that it may receive approval for biosimilar candidates, AVT02 and AVT04, in the United States. Stock rises.
0
Wall Street's Insights Into Key Metrics Ahead of Johnson & Johnson (JNJ) Q4 Earnings
https://www.zacks.com/stock/news/2212378/wall-street-s-insights-into-key-metrics-ahead-of-johnson-johnson-jnj-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2212378
Jan 18, 2024 - Get a deeper insight into the potential performance of Johnson & Johnson (JNJ) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
0
Top Analyst Reports for Johnson & Johnson, Micron Technology & Southern Company
https://www.zacks.com/commentary/2208227/top-analyst-reports-for-johnson-johnson-micron-technology-southern-company?cid=CS-ZC-FT-research_daily-2208227
Jan 10, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Micron Technology, Inc. (MU) and The Southern Company (SO).
0
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts
https://www.zacks.com/stock/news/2205270/johnson-johnson-jnj-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2205270
Jan 03, 2024 - In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $160.97, denoting a +0.63% change from the preceding trading day.
0
2 Best Warren Buffett Stocks to Buy for the Long Haul
https://www.fool.com/investing/2023/12/30/2-best-warren-buffett-stocks-to-buy-for-the-long/?source=iedfolrf0000001
Dec 30, 2023 - These companies need no introduction.
0
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
https://www.fool.com/investing/2023/12/29/there-are-only-5-dow-stocks-i-wouldnt-buy-in-2024/?source=iedfolrf0000001
Dec 29, 2023 - There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.
0
Is iShares Core High Dividend ETF (HDV) a Strong ETF Right Now?
https://www.zacks.com/stock/news/2203479/is-ishares-core-high-dividend-etf-hdv-a-strong-etf-right-now?cid=CS-ZC-FT-smart_beta_etf-2203479
Dec 29, 2023 - Smart Beta ETF report for HDV
0